Yoon CH, Ross MI, Gastman BR, Luke JJ, et al. Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial. Ann Surg Oncol 2025 Feb 1. doi: 10.1245/s10434-024-16642.
PMID: 39893343